Is complement factor H a susceptibility factor for IgA nephropathy?

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1405-1408

  Edey, Matthew ^a   Strain, Lisa ^b   Ward, Roy ^c   Ahmed, Saeed ^d   Thomas, Trevor ^e   Goodship, Timothy H J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^e CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Complement; Genetics; IgA nephropathy

Indexed keywords

COMPLEMENT FACTOR H;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BIOPSY; COHORT STUDIES; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT FACTOR H; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 62549104828     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.12.002     Document Type: Article

References (31)

1. Abe K., Miyazaki M., Koji T., Furusu A., Shioshita K., Tsukasaki S., Ozono Y., Harada T., Sakai H., and Kohno S. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy. Nephron 87 (2001) 231-239
2. Bene M.C., and Faure G.C. Composition of mesangial deposits in IgA nephropathy: complement factors. Nephron 46 (1987) 219
3. Bisceglia L., Cerullo G., Forabosco P., Torres D.D., Scolari F., Di Perna M., Foramitti M., Amoroso A., Bertok S., Floege J., Mertens P.R., Zerres K., Alexopoulos E., Kirmizis D., Ermelinda M., Zelante L., and Schena F.P. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. American Journal of Human Genetics 79 (2006) 1130-1134
4. D'Amico G., Imbasciati E., Barbiano Di Belgioioso G., Bertoli S., Fogazzi G., Ferrario F., Fellin G., Ragni A., Colasanti G., Minetti L., et al. Idiopathic IgA mesangial nephropathy Clinical and histological study of 374 patients. Medicine (Baltimore) 64 (1985) 49-60
5. Endo M., Ohi H., Ohsawa I., Fujita T., Matsushita M., and Fujita T. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrology Dialysis Transplantation 13 (1998) 1984-1990
6. Endo M., Ohi H., Satomura A., Hidaka M., Ohsawa I., Fujita T., Kanmatsuse K., Matsushita M., and Fujita T. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy. Clinical Nephrology 55 (2001) 185-191
7. Filler G., Radhakrishnan S., Strain L., Hill A., Knoll G., and Goodship T.H.J. Challenges in the management of infantile factor H associated hemolytic uremic syndrome. Pediatric Nephrology 19 (2004) 908-911
8. Fremeaux-Bacchi V., Kemp E.J., Goodship J.A., Dragon-Durey M.A., Strain L., Loirat C., Deng H.W., and Goodship T.H.J. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. Journal of Medical Genetics 42 (2005) 852-856
9. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Hoiby N., Schwartz M., and Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. Journal of Clinical Investigation 104 (1999) 431-437
10. Gharavi A.G., Yan Y., Scolari F., Schena F.P., Frasca G.M., Ghiggeri G.M., Cooper K., Amoroso A., Viola B.F., Battini G., Caridi G., Canova C., Farhi A., Subramanian V., Nelson-Williams C., Woodford S., Julian B.A., Wyatt R.J., and Lifton R.P. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nature Genetics 26 (2000) 354-357
11. Gong R., Liu Z., and Li L. Mannose-binding lectin gene polymorphism associated with the patterns of glomerular immune deposition in IgA nephropathy. Scandinavian Journal of Urology & Nephrology 35 (2001) 228-232
12. Hiemstra P.S., Gorter A., Stuurman M.E., Van Es L.A., and Daha M.R. Activation of the alternative pathway of complement by human serum IgA. European Journal of Immunology 17 (1987) 321-326
13. Hsu S.I. Racial and genetic factors in IgA nephropathy. Seminars in Nephrology 28 (2008) 48-57
14. Ibels L.S., and Gyory A.Z. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 73 (1994) 79-102
15. Lhotta K., Wurzner R., and Konig P. Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrology Dialysis Transplantation 14 (1999) 881-886
16. Liu X.Q., Paterson A.D., He N., St George-Hyslop P., Rauta V., Gronhagen-Riska C., Laakso M., Thibaudin L., Berthoux F., Cattran D., and Pei Y. IL5RA and TNFRSF6B gene variants are associated with sporadic IgA nephropathy. Journal of the American Society of Nephrology 19 (2008) 1025-1033
17. Lucisano Valim Y.M., and Lachmann P.J. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clinical and Experimental Immunology 84 (1991) 1-8
18. Matsuda M., Shikata K., Wada J., Sugimoto H., Shikata Y., Kawasaki T., and Makino H. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 80 (1998) 408-413
19. Miyazaki R., Kuroda M., Akiyama T., Otani I., Tofuku Y., and Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clinical Nephrology 21 (1984) 335-340
20. Morita S., Sakai T., Okamoto N., Funabiki A., Okada Y., Hasegawa Y., Amano K., Yoshikawa N., and Kasuga M. Hemolytic uremic syndrome associated with immunoglobulin A nephropathy: a case report and review of cases of hemolytic uremic syndrome with glomerular disease. Internal Medicine 38 (1999) 495-499
21. Oortwijn B.D., Eijgenraam J.W., Rastaldi M.P., Roos A., Daha M.R., and van Kooten C. The role of secretory IgA and complement in IgA nephropathy. Seminars in Nephrology 28 (2008) 58-65
22. Oortwijn B.D., Roos A., Royle L., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Eijgenraam J.W., Dwek R.A., Daha M.R., Rudd P.M., and van Kooten C. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. Journal of the American Society of Nephrology 17 (2006) 3529-3539
23. Paterson A.D., Liu X.Q., Wang K., Magistroni R., Song X., Kappel J., Klassen J., Cattran D., St George-Hyslop P., and Pei Y. Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36. Journal of the American Society of Nephrology 18 (2007) 2408-2415
24. Pirulli D., Boniotto M., Vatta L., Crovella S., Spano A., Morgutti M., Zezlina S., Bertola L., Roccatello D., Scolari F., Peruzzi L., Savoldi S., and Amoroso A. Polymorphisms in the promoter region and at codon 54 of the MBL2 gene are not associated with IgA nephropathy. Nephrology Dialysis Transplantation 16 (2001) 759-764
25. Rauterberg E.W., Lieberknecht H.M., Wingen A.M., and Ritz E. Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney International 31 (1987) 820-829
26. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., and Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. Journal of Immunology 167 (2001) 2861-2868
27. Roos A., Rastaldi M.P., Calvaresi N., Oortwijn B.D., Schlagwein N., van Gijlswijk-Janssen D.J., Stahl G.L., Matsushita M., Fujita T., van Kooten C., and Daha M.R. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. Journal of the American Society of Nephrology 17 (2006) 1724-1734
28. Tomino Y., Endoh M., Nomoto Y., and Sakai H. Activation of complement by renal tissues from patients with IgA nephropathy. Journal of Clinical Pathology 34 (1981) 35-40
29. Wyatt R.J., Julian B.A., and Galla J.H. Properdin deficiency with IgA nephropathy. New England Journal of Medicine 305 (1981) 1097
30. Wyatt R.J., Julian B.A., Weinstein A., Rothfield N.F., and McLean R.H. Partial H (beta 1H) deficiency and glomerulonephritis in two families. Journal of Clinical Immunology 2 (1982) 110-117
31. Zwirner J., Burg M., Schulze M., Brunkhorst R., Gotze O., Koch K.M., and Floege J. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy. Kidney International 51 (1997) 1257-1264